Lumosa Therapeutics Co., Ltd. (TPEX:6535)
174.00
+1.00 (0.58%)
Apr 2, 2025, 10:45 AM CST
Lumosa Therapeutics Revenue
In the year 2024, Lumosa Therapeutics had annual revenue of 39.15M TWD, down -31.21%. Lumosa Therapeutics had revenue of 19.81M in the quarter ending December 31, 2024, with 7.25% growth.
Revenue
39.15M
Revenue Growth
-31.21%
P/S Ratio
n/a
Revenue / Employee
910.56K
Employees
43
Market Cap
29.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 39.15M | -17.76M | -31.21% |
Dec 31, 2023 | 56.92M | 30.27M | 113.63% |
Dec 31, 2022 | 26.64M | 9.28M | 53.45% |
Dec 31, 2021 | 17.36M | -4.29M | -19.81% |
Dec 31, 2020 | 21.65M | -150.39M | -87.42% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Pegavision | 6.82B |
Polaris Group | 107.00M |
Center Laboratories | 1.62B |